| The oncogenic transcription factor RUNX1/ETO corrupts cell cycle regulation to drive leukemic transformation N Martinez-Soria, L McKenzie, J Draper, A Ptasinska, H Issa, S Potluri, ... Cancer Cell 34 (4), 626-642. e8, 2018 | 96 | 2018 |
| DNA polymerase and mismatch repair exert distinct microsatellite instability signatures in normal and malignant human cells J Chung, YE Maruvka, S Sudhaman, J Kelly, NJ Haradhvala, V Bianchi, ... Cancer discovery 11 (5), 1176-1191, 2021 | 53 | 2021 |
| Effect of methotrexate/vitamin B12 on DNA methylation as a potential factor in leukemia treatment-related neurotoxicity VJ Forster, A McDonnell, R Theobald, JA McKay Epigenomics 9 (9), 1205-1218, 2017 | 38 | 2017 |
| Drug interactions may be important risk factors for methotrexate neurotoxicity, particularly in pediatric leukemia patients VJ Forster, FW van Delft, SF Baird, S Mair, R Skinner, C Halsey Cancer Chemotherapy and Pharmacology 78 (5), 1093-1096, 2016 | 37 | 2016 |
| The leukemia-associated RUNX1/ETO oncoprotein confers a mutator phenotype VJ Forster, MH Nahari, N Martinez-Soria, AK Bradburn, A Ptasinska, ... Leukemia 30 (1), 251-254, 2016 | 32 | 2016 |
| Readdressing the needs of cancer survivors during COVID-19: a path forward JM Jones, H Saeed, MS Katz, MB Lustberg, VJ Forster, L Nekhlyudov JNCI: Journal of the National Cancer Institute 113 (8), 955-961, 2021 | 31 | 2021 |
| A functional variant in the core promoter of the CD95 cell death receptor gene predicts prognosis in acute promyelocytic leukemia NJ Sunter, K Scott, R Hills, D Grimwade, S Taylor, LJ Worrillow, ... Blood, The Journal of the American Society of Hematology 119 (1), 196-205, 2012 | 29 | 2012 |
| CD19: a multifunctional immunological target molecule and its implications for Blineage acute lymphoblastic leukemia J Weiland, A Elder, V Forster, O Heidenreich, S Koschmieder, J Vormoor Pediatric blood & cancer 62 (7), 1144-1148, 2015 | 25 | 2015 |
| Life without mismatch repair MA Sanders, H Vöhringer, VJ Forster, L Moore, BB Campbell, Y Hooks, ... bioRxiv, 2021.04. 14.437578, 2021 | 21 | 2021 |
| Characterizing pain in long-term survivors of childhood cancer M Patton, VJ Forster, C Forbes, M Stokoe, M Noel, LE Carlson, KA Birnie, ... Supportive Care in Cancer 30, 295-303, 2022 | 20 | 2022 |
| Cancers from novel pole-mutant mouse models provide insights into polymerase-mediated hypermutagenesis and immune checkpoint blockade MA Galati, KP Hodel, MS Gams, S Sudhaman, T Bridge, WJ Zahurancik, ... Cancer research 80 (24), 5606-5618, 2020 | 16 | 2020 |
| Unique needs of childhood cancer survivors during the COVID-19 pandemic VJ Forster, F Schulte Supportive Care in Cancer 29 (1), 17-19, 2021 | 15 | 2021 |
| Genomic microsatellite signatures identify germline mismatch repair deficiency and risk of cancer onset J Chung, L Negm, V Bianchi, L Stengs, A Das, ZA Liu, S Sudhaman, ... Journal of Clinical Oncology 41 (4), 766-777, 2023 | 13 | 2023 |
| B-cell acute lymphoblastic leukemia with high mutation burden presenting in a child with constitutional mismatch repair deficiency. B Oshrine, N Grana, C Moore, J Nguyen, M Crenshaw, M Edwards, ... Blood Advances 3 (12), 1795-1798, 2019 | 8 | 2019 |
| There Is A Coronavirus Coloring Book Designed To Help Children Cope With The Pandemic V Forster Forbes. Recuperado de https://www. forbes. com/sites/victoriaforster/2020/04 …, 2020 | 5 | 2020 |
| Should nitrous oxide ever be used in oncology patients receiving methotrexate therapy? VJ Forster, G Bell, C Halsey Pediatric Anesthesia 30 (1), 9-16, 2020 | 5 | 2020 |
| The perceived impact of COVID-19 on the mental health status of adolescent and young adult survivors of childhood cancer and the development of a knowledge translation tool to … SHJ Hou, A Tran, S Cho, C Forbes, VJ Forster, M Stokoe, E Allapitan, ... Frontiers in Psychology 13, 867151, 2022 | 4 | 2022 |
| Lack of mask mandates leaves cancer patients feeling unprotected V Forster Cancer Therapy Advisor, 2022 | 3 | 2022 |
| Responses to COVID-19 vaccines vary in patients with hematologic malignancies V Forster Cancer Therapy Advisor, 2021 | 3 | 2021 |
| Phase 3 Trial for Oncolytic Viral Therapy Pexa-Vec in Advanced Liver Cancer Terminated Early V Forster Cancer Therapy Advisor, 2019 | 3 | 2019 |
Christina HalseyProfessor of Paediatric Haemato-OncologyVerified email at glasgow.ac.uk
